What is Clinatec?
Clinatec, officially known as The Edmond J. Safra Biomedical Research Center, operates at the intersection of cutting-edge healthcare and advanced micro- and nanoelectronics. Based in Grenoble, France, within the CEA research center, Clinatec employs a unique, multi-disciplinary approach. Its teams, comprising medical doctors, biologists, mathematicians, and engineers from institutions like CEA, Grenoble-Alpes University Hospital, Université Grenoble-Alpes, and INSERM, focus on pioneering diagnosis and treatment strategies for complex conditions such as neurodegenerative diseases, cancer, and motor disabilities. The center is also dedicated to developing innovative biomedical devices aimed at enhancing patient outcomes and quality of life.
How much funding has Clinatec raised?
Clinatec has raised a total of $10.6M across 1 funding round:
Unspecified
$10.6M
Unspecified (2016): $10.6M, investors not publicly disclosed
What's next for Clinatec?
The substantial enterprise-level funding and recent strategic investment signal a new phase of accelerated growth and development for Clinatec. This capital infusion is expected to fuel further research into its core areas, potentially leading to breakthroughs in personalized medicine and advanced therapeutic devices. The company's focus on multi-disciplinary collaboration positions it to tackle some of the most pressing challenges in modern healthcare, with future initiatives likely centered on scaling its research capabilities and translating innovations into tangible patient benefits.
See full Clinatec company page
